Growth Focus Cosette is a fast-growing branded specialty pharma with a recent portfolio expansion including seven branded products and strategic acquisitions, signaling opportunities to cross-sell dermatology and women’s health offerings, as well as leverage new product launches for channel expansion.

Commercial Leadership Recent leadership hires in Commercial and Brand leadership (CCO David Bell) indicate a vanguard push toward stronger market access, sales execution, and brand strategy, presenting a window to engage on collaborative go-to-market, market access partnerships, and co-developed promotional initiatives.

Regulatory & Quality New VP of Quality and Regulatory Affairs strengthens compliance and product lifecycle management, suggesting readiness for expanded product approvals, faster time-to-market for new SKUs, and opportunities to offer CDMO or regulatory services to support growth.

Global Footprint Past geographic adjustments include closing Adelaide offices and manufacturing assets, yet the company maintains US manufacturing in New Jersey and North Carolina; this points to potential near-term focus on US-market brands and distribution deals, with caution on international expansion timing.

Financial Levers Revenue scale falls in the mid hundreds of millions with PE-backed backing, presenting opportunities to discuss supply agreements, contract manufacturing, and strategic partnerships, including rights licensing or co-development deals to accelerate portfolio growth.